Acorda Therapeutics reported $-28697000 in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -14.79M 28.61M
Agios Pharmaceuticals AGIO:US $ -84.26M 1.47M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Anika Therapeutics ANIK:US $ 1.25M 7.88M
Arrowhead Research ARWR:US $ -63.37M 33.45M
Biogen BIIB:US $ 814.2M 255M
Cara Therapeutics CARA:US $ -1013000 29.73M
Clovis Oncology CLVS:US $ -67.4M 0.95M
Cytokinetics CYTK:US $ -76.09M 14.53M
Enanta Pharmaceuticals ENTA:US $ -33.39M 0.01M
Halozyme Therapeutics HALO:US $ 74.11M 17.41M
Insmed INSM:US $ -115292000 1.41M
Mannkind MNKD:US $ -4.43M 31.1M
Moderna Inc MRNA:US 3.55B 489M
Neurocrine Biosciences NBIX:US $ 30.5M 27M
Novartis NOVN:VX SF 4544M 120M
Teva Pharmaceutical TEVA:IT 382M 412M
Ultragenyx Pharmaceutical RARE:US $ -72.82M 49.15M